WashU Medicine Anesthesiology demonstrates leadership in migraine and pain research at AHSAM 2026 (Links to an external site)
Researchers from the WashU Medicine Department of Anesthesiology had an impactful presence at the American Headache Society (AHS) Annual Meeting, held June 4–7, 2026, in Orlando. With major awards, national recognition, and multiple scientific presentations, the department once again demonstrated its leadership in headache and migraine research.
Study identifies gene that may influence opioid addiction risk (Links to an external site)
Researchers at WashU Medicine have identified a gene that may help explain why some individuals are more likely than others to develop opioid addiction. The study builds on human genetic studies suggesting that the gene CNIH3 may influence how opioid use begins and develops over time.
Finding Relief from Phantom Limb Pain with Spinal Cord Stimulation (Links to an external site)
After a below-the-knee amputation, Jodi Evans experienced severe phantom limb pain that disrupted her sleep and daily life. A spinal cord stimulator helped reduce the pain, allowing her to rest and regain independence.
Environmental enrichment reduces fentanyl relapse in rats (Links to an external site)
A study by WashU Medicine researchers offers new insight into how environmental factors protect against opioid addiction and support recovery.
Gereau receives Ray Dingledine Award for Research Impact (Links to an external site)
Robert W. Gereau IV, PhD, the Dr. Seymour and Rose T. Brown Professor and vice chair for research in the Department of Anesthesiology at WashU Medicine, received the Ray Dingledine Award for Research Impact on March 6, 2026.
Creed appointed Associate Division Chief of Basic Research for WashU Medicine Pain Center (Links to an external site)
The Department of Anesthesiology is pleased to announce the appointment of Dr. Meaghan Creed as Associate Division Chief of Basic Research for the WashU Medicine Pain Center, effective March 1, 2026.
Study uncovers how delta opioid receptor could be harnessed for safer pain therapeutics (Links to an external site)
Sarah Bernhard, PhD, and Susovan Chowdhury, PhD, co-led a study showing how the delta opioid receptor could be targeted to develop safer, more effective pain treatments.
New compound stops common complications after intestinal surgery (Links to an external site)
Researchers, including Dr. Elgendy, developed a gut-restricted experimental drug that, in mice, improves nutrient absorption and protects the liver from damage after small bowel resection.
WashU Medicine Anesthesiology ranks No. 1 nationally in NIH funding, securing $30.6M (Links to an external site)
For the second consecutive year, the department leads the nation in NIH funding, earning $30.6 million to support 164 research projects and more than $37 million in total research awards.
Untangling chronic pain: Inside WashU Medicine’s holistic approach (Links to an external site)
At WashU Medicine Pain Center, specialists across disciplines collaborate to diagnose and treat how patients experience chronic pain.









